DOCSLIB.ORG

The Combined Impact of 12 Common Variants on Hypertension in Japanese Men, Considering GWAS Results

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
The Combined Impact of 12 Common Variants on Hypertension in Japanese Men, Considering GWAS Results Journal of Human Hypertension (2012) 26, 430–436 & 2012 Macmillan Publishers Limited All rights reserved 0950-9240/12 www.nature.com/jhh ORIGINAL ARTICLE The combined impact of 12 common variants on hypertension in Japanese men, considering GWAS results K Miyaki1,2, NC Htun2, Y Song1, S Ikeda2, M Muramatsu2 and T Shimbo1 1Division of Clinical Epidemiology, Department of Clinical Research and Informatics, National Center for Global Health and Medicine, Tokyo, Japan and 2Department of Molecular Epidemiology, Medical Research Institute, Tokyo Medical and Dental University, Tokyo, Japan Genome-wide association studies have identified several results for the CYP11B2 and PTGIS genes. Although there polymorphisms that appear to be on hypertension-sus- were no significant associations found for other variants, ceptible regions. We performed the current replication our results suggested there was a combined impact for study in order to evaluate the association of these loci 12 loci. Individuals carrying more risk alleles had a higher with hypertension in healthy Japanese males and then risk of hypertension (P for the slope ¼ 0.002). Blood examined the combined effect of 12 independent variants. pressures also increased in conjunction with an increas- Overall, 735 Japanese men from two independent co- ing risk allele score (P for trend ¼ 7.84 Â 10À6 and horts were recruited. Association with hypertension was 1.85 Â 10À5 for SBP and DBP, respectively). Our results assessed in 16 polymorphisms on 12 genes and 12 were confirmed the associations between hypertension or chosen to evaluate the combined impact. Polymorphisms blood pressure and four gene variants. We also found a on the COMT, ATP2B1, CYP11A1 and the CSK genes were significant combined effect of the 12 gene loci. confirmed to be associated with hypertension and blood Journal of Human Hypertension (2012) 26, 430–436; pressure (BP). Current findings also replicated previous doi:10.1038/jhh.2011.50; published online 2 June 2011 Keywords: combined impact; polymorphism; blood pressure; genome-wide association study Introduction wide association studies (GWAS) and the candidate gene approach. Hypertension is an important public health problem Recently, results from several GWAS identified found throughout the world. Hypertension preva- several single-nucleotide polymorphisms (SNPs) lence has been increasing, and as of 2006, an esti- that appeared to be related to hypertension in diffe- mated 972 million people in the world currently 1 rent population groups, such as SNP rs17249574, suffer from this problem. In Japan, more than which was near the ATP2B1 gene (encodes PMCA1, 33 million adults, or 45% of the adult population, 2 a plasma membrane calcium/calmodulin-dependent are estimated to have hypertension. Although the ATPase) reported by Korean researchers;3 SNP disease is thought to result from a complex interplay rs11191548, which is near the CYP17A1 (cyto- between genetic predisposition and environmental chrome P450, family 17, subfamily A, polypeptide influences, it is unclear as to what extent the genetic 1) gene and SNP rs1378942, which is near the CSK factors contribute to an individual’s susceptibility (c-src tyrosine kinase) gene identified by a European to hypertension. There are numerous genetic-based GWAS;4 the common variant rs11646213, which studies that have explored the basis of hypertension, was upstream of the CDH13 (cadherin 13 prepro- with the results providing a better understanding of tein) gene found in two European populations.5 The the underlying molecular mechanisms and making candidate gene approach has also been used to it possible to identify the common variants that are investigate associations of diseases with common associated with hypertension or blood pressure variants. Kamide et al. performed a large association (BP). The most used techniques include genome- study and suggested that GREB1 (gene regulated by estrogen in breast cancer 1) and HPCAL1 (hippocal- Correspondence: Dr K Miyaki, Division of Clinical Epidemiology, cin-like 1 protein), which previously revealed by Department of Clinical Research and Informatics, National Center genome-wide scans in Italian6 and Chinese7 were for Global Health and Medicine, Toyama 1-21-1, Shinjuku-ku, candidate hypertension-susceptibility genes in Tokyo 162-8655, Japan. Japanese.8 The polymorphisms of ABCA1 gene E-mail: [email protected] 9 Received 7 December 2010; revised 18 March 2011; accepted 12 (ATP binding cassette A1), ACADSB (short/ April 2011; published online 2 June 2011 branched chain acyl-CoA dehydrogenase),10 COMT Combined impact of 12 variants on hypertension K Miyaki et al 431 (catecholamine-O-methyltransferase)10 and PTK2B diastolic BP (DBP) X90 mm Hg, or the current use (protein kinase 2b)11 were also found to be determi- of an antihypertensive drug. All other subjects nants of BP and responsible for the development of were considered to be normotensive. The study hypertension in Japanese individuals. was approved by the ethics review committee of the In the current study, we chose 14 SNPs in 10 genes Medical Research Institute of Tokyo Medical and that had been previously reported by GWAS or Dental University. All participants provided written were from candidate gene studies. After genotyping informed consent. them in two unrelated Japanese cohorts, we were able to replicate associations in the general Japanese population. In addition, our previous results have Genotyping discovered several SNPs that were associated with Genomic DNA was extracted from the peripheral hypertension in Japanese men, including C-344 blood of each subject by conventional methodology. T SNP of the CYP11B2 gene12 and C1117A SNP of Genotyping for all polymorphisms was performed the PTGIS gene (unpublished). In the current study, by PCR using a TaqMan genotyping assay (ABI) we also included these polymorphisms and per- followed by allelic discrimination analysis using formed a multiple regression analysis in order to SDS software (Applied Biosystems, Carlsbad, CA, evaluate the combined risk for BP from these 12 loci USA). For each sample, 10 ng of purified DNA was in our samples. mixed with 0.25 mlof20Â SNP genotyping assay mix that contained forward and reverse primers, VIC and FAM probes, 2.5 ul of TaqMan universal PCR Subjects and methods master mix and 2.25 ml of Dnase-free water. PCR amplification was performed by using the Applied Subjects Biosystems 9700 Thermal Cycler, with holding A total of 735 Japanese men from two separate temperatures of 90 1C for 10 min, 40 cycles of the occupational cohorts participated in the current denaturation temperature at 92 1C for 15 s and an study (Table 1). The first cohort, which has been annealing temperature of 60 1C for 1 min, with a 12 described elsewhere, comprised of 311 popula- final cooling step at 4 1C. tion-based Japanese men who worked for a company Following PCR, allelic discrimination was per- in Kanagawa Prefecture. The second cohort com- formed by using the Sequence Detection System prised 424 population-based Japanese men in Kyoto (ABI PRISM 7900HT, USA, SDS software package Prefecture who worked for a subsidiary of the version 2.2.1). We obtained successful genotyping first company. Information on age, current smoking call rates of 499.98% for the whole characterized status, drinking and the energy intake of all subjects sample. was obtained by means of a self-reported question- naire. A food frequency questionnaire was used for this purpose. Medical history was acquired Statistical analysis by interview. Height and weight were measured, The allele frequencies were determined by direct with the body mass index calculated as weight in counting. Deviation of the genotype distribution kilograms divided by height in meters squared. After from the Hardy–Weinberg disequilibrium was con- subjects rested quietly for at least 10 min in a supine firmed by a w2-test. Difference in the mean values of position, BP was measured using a posterior wall age, clinical characteristics, current smoking status, velocity/ankle-brachial index device (Nippon Colin, drinking and energy intake levels between the Aichi, Japan). Pressure was measured twice, with genotype groups were compared by an analysis of the average mean value then recorded. Hypertension variance or w2-test. Logistic regression analyses were was defined as a systolic BP (SBP) X140 mm Hg or a performed in order to examine the relationship Table 1 Baseline characteristics of the subjects Characteristics Total subjects (n ¼ 735) Normotensive (n ¼ 474) Hypertensive (n ¼ 261) Age (years) 47.0±8.9 45.3±9.2 50.1±7.4 BMI (kg mÀ2) 23.4±3.4 22.8±3.0 24.6±3.8 Systolic blood pressure (mm Hg) 129.9±17.5 120.1±10.3 147.8±13.2 Diastolic blood pressure (mm Hg) 79.8±11.8 73.5±8.0 91.1±8.6 Total serum cholesterol (mg dlÀ1) 203.0±34.5 199.0±33.4 210.3±35.4 Serum triglycerides (mg dlÀ1) 151.7±118.1 144.1±113.2 165.7±125.7 Serum HDL-cholesterol (mg dlÀ1) 56.7±14.4 57.0±13.9 56.3±15.4 Salt intake (g per day) 9.5±3.4 9.5±3.4 9.5±3.5 Energy intake (kJ per day) 7675.1±2190.3 7664.3±2179.4 7694.4±2214.6 Current smoking (%) 69.9 71.6 66.9 Alcohol use (%) 73.0 71.1 76.3 Abbreviations: BMI, body mass index; HDL, high-density lipoprotein. Data are presented as mean±s.d. or percentage. Journal of Human Hypertension Combined impact of 12 variants on hypertension K Miyaki et al 432 between the genotype and hypertension, as adjusted and body mass index were 47.0±8.9 years and for potential confounders, which might correlate to 23.4±3.4 kg mÀ2, respectively. The total prevalence BP, such as age, current smoking status and drink- of hypertension was 35.5% in our subjects.
Load more

Recommended publications
  • Impaired Hepatic Drug and Steroid Metabolism in Congenital Adrenal
    European Journal of Endocrinology (2010) 163 919–924 ISSN 0804-4643 CLINICAL STUDY Impaired hepatic drug and steroid metabolism in congenital adrenal hyperplasia due to P450 oxidoreductase deficiency Dorota Tomalik-Scharte1, Dominique Maiter2, Julia Kirchheiner3, Hannah E Ivison, Uwe Fuhr1 and Wiebke Arlt School of Clinical and Experimental Medicine, Centre for Endocrinology, Diabetes and Metabolism (CEDAM), University of Birmingham, Birmingham B15 2TT, UK, 1Department of Pharmacology, University Hospital, University of Cologne, 50931 Cologne, Germany, 2Department of Endocrinology, University Hospital Saint Luc, 1200 Brussels, Belgium and 3Department of Pharmacology of Natural Products and Clinical Pharmacology, University of Ulm, 89019 Ulm, Germany (Correspondence should be addressed to W Arlt; Email: [email protected]) Abstract Objective: Patients with congenital adrenal hyperplasia due to P450 oxidoreductase (POR) deficiency (ORD) present with disordered sex development and glucocorticoid deficiency. This is due to disruption of electron transfer from mutant POR to microsomal cytochrome P450 (CYP) enzymes that play a key role in glucocorticoid and sex steroid synthesis. POR also transfers electrons to all major drug- metabolizing CYP enzymes, including CYP3A4 that inactivates glucocorticoid and oestrogens. However, whether ORD results in impairment of in vivo drug metabolism has never been studied. Design: We studied an adult patient with ORD due to homozygous POR A287P, the most frequent POR mutation in Caucasians, and her clinically unaffected, heterozygous mother. The patient had received standard dose oestrogen replacement from 17 until 37 years of age when it was stopped after she developed breast cancer. Methods: Both subjects underwent in vivo cocktail phenotyping comprising the oral administration of caffeine, tolbutamide, omeprazole, dextromethorphan hydrobromide and midazolam to assess the five major drug-metabolizing CYP enzymes.
    [Show full text]
  • Molecular Mechanisms Underlying Noncoding Risk Variations in Psychiatric Genetic Studies
    OPEN Molecular Psychiatry (2017) 22, 497–511 www.nature.com/mp REVIEW Molecular mechanisms underlying noncoding risk variations in psychiatric genetic studies X Xiao1,2, H Chang1,2 and M Li1 Recent large-scale genetic approaches such as genome-wide association studies have allowed the identification of common genetic variations that contribute to risk architectures of psychiatric disorders. However, most of these susceptibility variants are located in noncoding genomic regions that usually span multiple genes. As a result, pinpointing the precise variant(s) and biological mechanisms accounting for the risk remains challenging. By reviewing recent progresses in genetics, functional genomics and neurobiology of psychiatric disorders, as well as gene expression analyses of brain tissues, here we propose a roadmap to characterize the roles of noncoding risk loci in the pathogenesis of psychiatric illnesses (that is, identifying the underlying molecular mechanisms explaining the genetic risk conferred by those genomic loci, and recognizing putative functional causative variants). This roadmap involves integration of transcriptomic data, epidemiological and bioinformatic methods, as well as in vitro and in vivo experimental approaches. These tools will promote the translation of genetic discoveries to physiological mechanisms, and ultimately guide the development of preventive, therapeutic and prognostic measures for psychiatric disorders. Molecular Psychiatry (2017) 22, 497–511; doi:10.1038/mp.2016.241; published online 3 January 2017 RECENT GENETIC ANALYSES OF NEUROPSYCHIATRIC neurodevelopment and brain function. For example, GRM3, DISORDERS GRIN2A, SRR and GRIA1 were known to involve in the neuro- Schizophrenia, bipolar disorder, major depressive disorder and transmission mediated by glutamate signaling and synaptic autism are highly prevalent complex neuropsychiatric diseases plasticity.
    [Show full text]
  • Supplementary Table S4. FGA Co-Expressed Gene List in LUAD
    Supplementary Table S4. FGA co-expressed gene list in LUAD tumors Symbol R Locus Description FGG 0.919 4q28 fibrinogen gamma chain FGL1 0.635 8p22 fibrinogen-like 1 SLC7A2 0.536 8p22 solute carrier family 7 (cationic amino acid transporter, y+ system), member 2 DUSP4 0.521 8p12-p11 dual specificity phosphatase 4 HAL 0.51 12q22-q24.1histidine ammonia-lyase PDE4D 0.499 5q12 phosphodiesterase 4D, cAMP-specific FURIN 0.497 15q26.1 furin (paired basic amino acid cleaving enzyme) CPS1 0.49 2q35 carbamoyl-phosphate synthase 1, mitochondrial TESC 0.478 12q24.22 tescalcin INHA 0.465 2q35 inhibin, alpha S100P 0.461 4p16 S100 calcium binding protein P VPS37A 0.447 8p22 vacuolar protein sorting 37 homolog A (S. cerevisiae) SLC16A14 0.447 2q36.3 solute carrier family 16, member 14 PPARGC1A 0.443 4p15.1 peroxisome proliferator-activated receptor gamma, coactivator 1 alpha SIK1 0.435 21q22.3 salt-inducible kinase 1 IRS2 0.434 13q34 insulin receptor substrate 2 RND1 0.433 12q12 Rho family GTPase 1 HGD 0.433 3q13.33 homogentisate 1,2-dioxygenase PTP4A1 0.432 6q12 protein tyrosine phosphatase type IVA, member 1 C8orf4 0.428 8p11.2 chromosome 8 open reading frame 4 DDC 0.427 7p12.2 dopa decarboxylase (aromatic L-amino acid decarboxylase) TACC2 0.427 10q26 transforming, acidic coiled-coil containing protein 2 MUC13 0.422 3q21.2 mucin 13, cell surface associated C5 0.412 9q33-q34 complement component 5 NR4A2 0.412 2q22-q23 nuclear receptor subfamily 4, group A, member 2 EYS 0.411 6q12 eyes shut homolog (Drosophila) GPX2 0.406 14q24.1 glutathione peroxidase
    [Show full text]
  • Cytochrome P450
    COVID-19 is an emerging, rapidly evolving situation. Get the latest public health information from CDC: https://www.coronavirus.gov . Get the latest research from NIH: https://www.nih.gov/coronavirus. Share This Page Search Health Conditions Genes Chromosomes & mtDNA Classroom Help Me Understand Genetics Cytochrome p450 Enzymes produced from the cytochrome P450 genes are involved in the formation (synthesis) and breakdown (metabolism) of various molecules and chemicals within cells. Cytochrome P450 enzymes Learn more about the cytochrome play a role in the synthesis of many molecules including steroid hormones, certain fats (cholesterol p450 gene group: and other fatty acids), and acids used to digest fats (bile acids). Additional cytochrome P450 enzymes metabolize external substances, such as medications that are ingested, and internal substances, such Biochemistry (Ofth edition, 2002): The as toxins that are formed within cells. There are approximately 60 cytochrome P450 genes in humans. Cytochrome P450 System is Widespread Cytochrome P450 enzymes are primarily found in liver cells but are also located in cells throughout the and Performs a Protective Function body. Within cells, cytochrome P450 enzymes are located in a structure involved in protein processing Biochemistry (fth edition, 2002): and transport (endoplasmic reticulum) and the energy-producing centers of cells (mitochondria). The Cytochrome P450 Mechanism (Figure) enzymes found in mitochondria are generally involved in the synthesis and metabolism of internal substances, while enzymes in the endoplasmic reticulum usually metabolize external substances, Indiana University: Cytochrome P450 primarily medications and environmental pollutants. Drug-Interaction Table Common variations (polymorphisms) in cytochrome P450 genes can affect the function of the Human Cytochrome P450 (CYP) Allele enzymes.
    [Show full text]
  • +3 Oxidation State) Methyltransferase (AS3MT
    Environmental and Molecular Mutagenesis 58:411^422 (2017) Research Article Associations between Arsenic (13OxidationState) Methyltransferase (AS3MT) and N-6 Adenine-specific DNA Methyltransferase1 (N6AMT1) Polymorphisms, Arsenic Metabolism, and Cancer Risk in a Chilean Population Rosemarie de la Rosa,1 Craig Steinmaus,1 Nicholas K. Akers,1 Lucia Conde,1 Catterina Ferreccio,2 David Kalman,3 Kevin R. Zhang,1 Christine F.Skibola,1 Allan H. Smith,1 Luoping Zhang,1 and Martyn T.Smith1* 1Superfund Research Program, Divisions of Environmental Health Sciences and Epidemiology, School of Public Health, University of California, Berkeley, California 2Departamento de Salud Publica, Facultad de Medicina, Pontificia Universidad Catolica de Chile, Advanced Center for Chronic Diseases, ACCDiS, Santiago, Chile 3Department of Environmental & Occupational Health Sciences, School of Public Health, University of Washington, Seattle, Washington, DC Inter-individual differences in arsenic metabolism have gene. We found several AS3MT polymorphisms asso- been linked to arsenic-related disease risks. Arsenic ciated with both urinary arsenic metabolite profiles (13) methyltransferase (AS3MT) is the primary and cancer risk. For example, compared to wildtypes, enzyme involved in arsenic metabolism, and we previ- individuals carrying minor alleles in AS3MT ously demonstrated in vitro that N-6 adenine-specific rs3740393 had lower %MMA (mean differ- DNA methyltransferase 1 (N6AMT1) also methylates ence 521.9%, 95% CI: 23.3, 20.4), higher the toxic inorganic arsenic (iAs) metabolite, monome- %DMA (mean difference 5 4.0%, 95% CI: 1.5, 6.5), thylarsonous acid (MMA), to the less toxic dimethylar- and lower odds ratios for bladder (OR 5 0.3; 95% sonic acid (DMA). Here, we evaluated whether CI: 0.1–0.6) and lung cancer (OR 5 0.6; 95% CI: AS3MT and N6AMT1 gene polymorphisms alter 0.2–1.1).
    [Show full text]
  • Bioactivity of Curcumin on the Cytochrome P450 Enzymes of the Steroidogenic Pathway
    International Journal of Molecular Sciences Article Bioactivity of Curcumin on the Cytochrome P450 Enzymes of the Steroidogenic Pathway Patricia Rodríguez Castaño 1,2, Shaheena Parween 1,2 and Amit V Pandey 1,2,* 1 Pediatric Endocrinology, Diabetology, and Metabolism, University Children’s Hospital Bern, 3010 Bern, Switzerland; [email protected] (P.R.C.); [email protected] (S.P.) 2 Department of Biomedical Research, University of Bern, 3010 Bern, Switzerland * Correspondence: [email protected]; Tel.: +41-31-632-9637 Received: 5 September 2019; Accepted: 16 September 2019; Published: 17 September 2019 Abstract: Turmeric, a popular ingredient in the cuisine of many Asian countries, comes from the roots of the Curcuma longa and is known for its use in Chinese and Ayurvedic medicine. Turmeric is rich in curcuminoids, including curcumin, demethoxycurcumin, and bisdemethoxycurcumin. Curcuminoids have potent wound healing, anti-inflammatory, and anti-carcinogenic activities. While curcuminoids have been studied for many years, not much is known about their effects on steroid metabolism. Since many anti-cancer drugs target enzymes from the steroidogenic pathway, we tested the effect of curcuminoids on cytochrome P450 CYP17A1, CYP21A2, and CYP19A1 enzyme activities. When using 10 µg/mL of curcuminoids, both the 17α-hydroxylase as well as 17,20 lyase activities of CYP17A1 were reduced significantly. On the other hand, only a mild reduction in CYP21A2 activity was observed. Furthermore, CYP19A1 activity was also reduced up to ~20% of control when using 1–100 µg/mL of curcuminoids in a dose-dependent manner. Molecular docking studies confirmed that curcumin could dock onto the active sites of CYP17A1, CYP19A1, as well as CYP21A2.
    [Show full text]
  • Arsenic-Associated Diabetes: Mechanisms and the Role of Arsenic Metabolism
    ARSENIC-ASSOCIATED DIABETES: MECHANISMS AND THE ROLE OF ARSENIC METABOLISM Madelyn C. Huang A dissertation submitted to the faculty at the University of North Carolina at Chapel Hill in partial fulfillment of the requirements for the degree of Doctor of Philosophy in the Curriculum of Toxicology within the School of Medicine. Chapel Hill 2018 Approved by: Miroslav Stýblo Rebecca Fry Ilona Jaspers Eric Klett Zuzana Drobná © 2018 Madelyn C. Huang ALL RIGHTS RESERVED ii ABSTRACT Madelyn C. Huang: Arsenic-associated diabetes: mechanisms and the role of arsenic metabolism (Under the direction of Miroslav Stýblo) Inorganic arsenic (iAs) is a ubiquitous drinking water and food contaminant. Chronic exposure to iAs has been linked to diabetes mellitus in many populations. Experimental studies support these associations and suggest mechanisms, but the precise pathogenesis of iAs- associated diabetes is unclear. Efficient metabolism of iAs through methylation, catalyzed by arsenic (+3) methyltransferase (AS3MT), influences the risk of iAs-associated disease. Additionally, higher intake of methyl donor nutrients such as folate and methylcobalamin (B12) has been linked to increased efficiency of iAs metabolism and lowered disease risk. However, while metabolism of iAs facilitates its excretion from the body, iAs metabolites are more toxic than iAs itself. The role of iAs metabolism in iAs toxicity is understudied, especially in cardiometabolic disease. Understanding how iAs metabolism affects iAs-associated diabetes will help design appropriate intervention strategies and improve risk assessment. This project investigated how iAs metabolism influences iAs-associated diabetes. First, we compared metabolite profiles of C57BL6 (WT) with As3mt-KO (KO) mice, which cannot methylate iAs, with and without exposure to iAs.
    [Show full text]
  • Supp Table 6.Pdf
    Supplementary Table 6. Processes associated to the 2037 SCL candidate target genes ID Symbol Entrez Gene Name Process NM_178114 AMIGO2 adhesion molecule with Ig-like domain 2 adhesion NM_033474 ARVCF armadillo repeat gene deletes in velocardiofacial syndrome adhesion NM_027060 BTBD9 BTB (POZ) domain containing 9 adhesion NM_001039149 CD226 CD226 molecule adhesion NM_010581 CD47 CD47 molecule adhesion NM_023370 CDH23 cadherin-like 23 adhesion NM_207298 CERCAM cerebral endothelial cell adhesion molecule adhesion NM_021719 CLDN15 claudin 15 adhesion NM_009902 CLDN3 claudin 3 adhesion NM_008779 CNTN3 contactin 3 (plasmacytoma associated) adhesion NM_015734 COL5A1 collagen, type V, alpha 1 adhesion NM_007803 CTTN cortactin adhesion NM_009142 CX3CL1 chemokine (C-X3-C motif) ligand 1 adhesion NM_031174 DSCAM Down syndrome cell adhesion molecule adhesion NM_145158 EMILIN2 elastin microfibril interfacer 2 adhesion NM_001081286 FAT1 FAT tumor suppressor homolog 1 (Drosophila) adhesion NM_001080814 FAT3 FAT tumor suppressor homolog 3 (Drosophila) adhesion NM_153795 FERMT3 fermitin family homolog 3 (Drosophila) adhesion NM_010494 ICAM2 intercellular adhesion molecule 2 adhesion NM_023892 ICAM4 (includes EG:3386) intercellular adhesion molecule 4 (Landsteiner-Wiener blood group)adhesion NM_001001979 MEGF10 multiple EGF-like-domains 10 adhesion NM_172522 MEGF11 multiple EGF-like-domains 11 adhesion NM_010739 MUC13 mucin 13, cell surface associated adhesion NM_013610 NINJ1 ninjurin 1 adhesion NM_016718 NINJ2 ninjurin 2 adhesion NM_172932 NLGN3 neuroligin
    [Show full text]
  • Bridging Cell Surface Receptor with Nuclear Receptors in Control of Bile Acid Homeostasis Shuangwei LI§ , *, Andrew NI, Gen-Sheng FENG
    Acta Pharmacologica Sinica (2015) 36: 113–118 npg © 2015 CPS and SIMM All rights reserved 1671-4083/15 $32.00 www.nature.com/aps Review Bridging cell surface receptor with nuclear receptors in control of bile acid homeostasis Shuangwei LI§ , *, Andrew NI, Gen-sheng FENG Department of Pathology and Division of Biological Sciences, University of California San Diego, La Jolla, CA 92093-0864, USA Bile acids (BAs) are traditionally considered as “physiological detergents” for emulsifying hydrophobic lipids and vitamins due to their amphipathic nature. But accumulating clinical and experimental evidence shows an association between disrupted BA homeostasis and various liver disease conditions including hepatitis infection, diabetes and cancer. Consequently, BA homeostasis regulation has become a field of heavy interest and investigation. After identification of the Farnesoid X Receptor (FXR) as an endogenous receptor for BAs, several nuclear receptors (SHP, HNF4α, and LRH-1) were also found to be important in regulation of BA homeostasis. Some post-translational modifications of these nuclear receptors have been demonstrated, but their physiological significance is still elusive. Gut secrets FGF15/19 that can activate hepatic FGFR4 and its downstream signaling cascade, leading to repressed hepatic BA biosynthesis. However, the link between the activated kinases and these nuclear receptors is not fully elucidated. Here, we review the recent literature on signal crosstalk in BA homeostasis. Keywords: bile acids; FXR; HNF4α; LXR; FGFR4; FGF15/19; Shp2; phosphorylation Acta Pharmacologica Sinica (2015) 36: 113–118; doi: 10.1038/aps.2014.118; published online 15 Dec 2014 Introduction Na+-taurocholate cotransporting polypeptide (NTCP)[3]. HBV Cholesterol is directly converted by a series of chemical reac- infection causes increased BA biosynthesis[4].
    [Show full text]
  • Methyltransferase (AS3MT) and N-6 Adenine-Specific DNA Methyltransferase 1 (N6AMT1) Polymorphisms, Arsenic Metabolism, and Cancer Risk in a Chilean Population
    HHS Public Access Author manuscript Author ManuscriptAuthor Manuscript Author Environ Manuscript Author Mol Mutagen. Author Manuscript Author manuscript; available in PMC 2018 July 01. Published in final edited form as: Environ Mol Mutagen. 2017 July ; 58(6): 411–422. doi:10.1002/em.22104. Associations between arsenic (+3 oxidation state) methyltransferase (AS3MT) and N-6 adenine-specific DNA methyltransferase 1 (N6AMT1) polymorphisms, arsenic metabolism, and cancer risk in a Chilean population Rosemarie de la Rosa1, Craig Steinmaus1, Nicholas K Akers1, Lucia Conde1, Catterina Ferreccio2, David Kalman3, Kevin R Zhang1, Christine F Skibola1, Allan H Smith1, Luoping Zhang1, and Martyn T Smith1 1Superfund Research Program, School of Public Health, University of California, Berkeley, CA 2Pontificia Universidad Católica de Chile, Santiago, Chile, Advanced Center for Chronic Diseases, ACCDiS 3School of Public Health, University of Washington, Seattle, WA Abstract Inter-individual differences in arsenic metabolism have been linked to arsenic-related disease risks. Arsenic (+3) methyltransferase (AS3MT) is the primary enzyme involved in arsenic metabolism, and we previously demonstrated in vitro that N-6 adenine-specific DNA methyltransferase 1 (N6AMT1) also methylates the toxic iAs metabolite, monomethylarsonous acid (MMA), to the less toxic dimethylarsonic acid (DMA). Here, we evaluated whether AS3MT and N6AMT1 gene polymorphisms alter arsenic methylation and impact iAs-related cancer risks. We assessed AS3MT and N6AMT1 polymorphisms and urinary arsenic metabolites (%iAs, %MMA, %DMA) in 722 subjects from an arsenic-cancer case-control study in a uniquely exposed area in northern Chile. Polymorphisms were genotyped using a custom designed multiplex, ligation-dependent probe amplification (MLPA) assay for 6 AS3MT SNPs and 14 tag SNPs in the N6AMT1 gene.
    [Show full text]
  • Cytochrome P450
    Cytochrome P450 • R.T. Williams - in vivo, 1947. Brodie – in vitro, from late 40s till the 60s. • Cytochrome P450 enzymes (hemoproteins) play an important role in the intra-cellular metabolism. • Exist in prokaryotic and eukaryotic (plants insects fish and mammal, as well as microorganisms) • Different P450 enzymes can be found in almost any tissue: liver, kidney, lungs and even brain. • Plays important role in drugs metabolism and xenobiotics. P450 Reactions • Cytochrome P450 enzymes catalyze thousands of different reaction. • Oxidative reactions. SH + O2 + NADPH + H+ SOH + H2O + NADPH+ • The protein structure is believed to determines the catalytic specificity through complementarity to the transition state. General Features of Cytochrome P450 Catalysis 1. Substrate binding (presumably near the site of the heme ligand) 2. 1-electorn reduction of the iron by flavprotein NADPH cytochrome P450 reductase 3. Reaction of ferrous iron with O2 to yield an unstable FeO2 complex 4. Addition of the second electron from NADPH or cytochrome b5 5. Heterolytic scission of the FeO-O(H) bond to generate a formal (FeO)3+ 6. Oxidation of the substrate. 1. Formal abstraction of hydrogen atom or electron 2. Radical recombination 7. Release of the product. • Oxidative Reactions • Carbon Hydroxylation • Heteroatom Hydroxylation • Heteroatom Release • Rearangement Related to Heteroatom Oxidations • Oxidation of π-System • Hypervalent Oxygen substrate • Reductive Reactions Humans CYP450 -18 families, 43 subfamilies • CYP1 drug metabolism (3 subfamilies, 3 genes,
    [Show full text]
  • The Human Protein Methyltransferases
    The human protein methyltransferases Methyltransferases are enzymes that facilitate the transfer of a methyl (–CH3) group to of methyl ‘marks’ as regulators of gene expression. Human protein methyltransferases specific nucleophilic sites on proteins, nucleic acids or other biomolecules. They share (PMTs) fall into two major families—protein lysine methyltransferases (PKMTs) and a reaction mechanism in which the nucleophilic acceptor site attacks the electrophilic protein arginine methyltransferases (PRMTs)—that are distinguishable by the amino carbon of S-adenosyl-L-methionine (SAM) in an SN2 displacement reaction that pro- acid that accepts the methyl group and by the conserved sequences of their respective duces a methylated biomolecule and S-adenosyl-L-homocysteine (SAH) as a byprod- catalytic domains. Given their involvement in many cellular processes, PMTs have at- Supplement to Nature Publishing Group Journals uct. Methylation reactions are essential transformations in small-molecule metabolism, tracted attention as potential drug targets, spurring the search for small-molecule PMT and methylation is a common modification of DNA and RNA. The recent discovery of inhibitors. Several classes of inhibitors have been identified, but new specific chemi- dynamic and reversible methylation of amino acid side chains of chromatin proteins, cal probes that are active in cells will be required to elucidate the biological roles of particularly within the N-terminal tail of histone proteins, has revealed the importance PMTs and serve as potent leads for PMT-focused drug development. Protein arginine methyltransferases (PRMTs) Protein lysine methyltransferases (PKMTs) H CH3 CH3 H3C H C CH3 H The phylogenetic tree shows 51 genes predicted to encode PKMTs, which are positioned H H H H H 3 The human PRMT phylogenetic tree comprises 45 predicted enzymes including the PKMT H N H N H N H H3C N H H3C N H 1 N H N CH3 N CH3 CH3 1 N in the tree on the basis of the similarities of their amino acid sequences .
    [Show full text]